{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:09:03Z","timestamp":1784758143498,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-024-05765-3","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:05:17Z","timestamp":1725609917000},"page":"4817-4825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Regression effect of renin\u2013angiotensin\u2013aldosterone system inhibitors on Kawasaki disease patients with coronary artery aneurysm: a prospective, observational study"],"prefix":"10.1007","volume":"183","author":[{"given":"Eisuke","family":"Suganuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Hokosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujito","family":"Numano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Furuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Shiono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Fuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Fukazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"5765_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1253\/circj.CJ-17-0433","volume":"82","author":"R Fukazawa","year":"2017","unstructured":"Fukazawa R, Kobayashi T, Mikami M, Saji T, Hamaoka K, Kato H, Suzuki H, Tsuda E, Ayusawa M, Miura M et al (2017) Nationwide survey of patients with giant coronary aneurysm secondary to Kawasaki disease 1999\u20132010 in Japan. Circ J 82:239\u2013246. https:\/\/doi.org\/10.1253\/circj.CJ-17-0433","journal-title":"Circ J"},{"issue":"5","key":"5765_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.0030","volume":"172","author":"M Miura","year":"2018","unstructured":"Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, Fuse S, Hamaoka K, Hirono K, Kato T et al (2018) Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events. JAMA Pediatr 172(5):e180030. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.0030","journal-title":"JAMA Pediatr"},{"key":"5765_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00431-022-04719-x","volume":"182","author":"Y Koyama","year":"2023","unstructured":"Koyama Y, Miura M, Kobayashi T, Hokosaki T, Suganuma E, Numano F, Furuno K, Shiono J, Ebata R, Fuse S et al (2023) A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement. Eur J Pediatr 182:633\u2013640. https:\/\/doi.org\/10.1007\/s00431-022-04719-x","journal-title":"Eur J Pediatr"},{"key":"5765_CR4","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","volume":"94","author":"H Kato","year":"1996","unstructured":"Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379\u20131385. https:\/\/doi.org\/10.1161\/01.CIR.94.6.1379","journal-title":"Circulation"},{"key":"5765_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003289","volume":"5","author":"KG Friedman","year":"2016","unstructured":"Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR et al (2016) Coronary artery aneurysms in Kawasaki disease: Risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 5:e003289. https:\/\/doi.org\/10.1161\/JAHA.116.003289","journal-title":"J Am Heart Assoc"},{"key":"5765_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022417","volume":"12","author":"T Kato","year":"2023","unstructured":"Kato T, Miura M, Kobayashi T, Kaneko T, Fukushima N, Suda K, Maeda J, Shimoyama S, Shiono J, Hirono K et al (2023) Analysis of coronary arterial aneurysm regression in patients with Kawasaki disease by aneurysm severity: factors associated with regression. J Am Heart Assoc 12:e022417. https:\/\/doi.org\/10.1161\/JAHA.121.022417","journal-title":"J Am Heart Assoc"},{"key":"5765_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/ajh\/hpac018","volume":"35","author":"BI L\u00e9vy","year":"2022","unstructured":"L\u00e9vy BI, Mourad JJ (2022) Renin angiotensin blockers and cardiac protection: from basis to clinical trials. Am J Hypertens 35:293\u2013302. https:\/\/doi.org\/10.1093\/ajh\/hpac018","journal-title":"Am J Hypertens"},{"key":"5765_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jacc.2005.09.055","volume":"47","author":"J McMurray","year":"2006","unstructured":"McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A et al (2006) The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). J Am Coll Cardiol 47:726\u2013733. https:\/\/doi.org\/10.1016\/j.jacc.2005.09.055","journal-title":"J Am Coll Cardiol"},{"key":"5765_CR9","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1681\/ASN.2006090967","volume":"18","author":"E Suganuma","year":"2007","unstructured":"Suganuma E, Babaev VR, Motojima M, Zuo Y, Ayabe N, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V (2007) Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques. J Am Soc Nephrol 18:2311\u20132319. https:\/\/doi.org\/10.1681\/ASN.2006090967","journal-title":"J Am Soc Nephrol"},{"key":"5765_CR10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1161\/01.CIR.103.6.799","volume":"103","author":"B Hornig","year":"2001","unstructured":"Hornig B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A, Tatge H, Drexler H (2001) Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 103:799\u2013805. https:\/\/doi.org\/10.1161\/01.CIR.103.6.799","journal-title":"Circulation"},{"key":"5765_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C et al (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117\u2013121. https:\/\/doi.org\/10.1126\/science.1124287","journal-title":"Science"},{"key":"5765_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/CIRCGENETICS.110.940858","volume":"4","author":"C Shimizu","year":"2011","unstructured":"Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, Molkara D, Frazer JR, Sun S, Baker AL, Newburger JW et al (2011) Transforming growth factor-signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet 4:16\u201325. https:\/\/doi.org\/10.1161\/CIRCGENETICS.110.940858","journal-title":"Circ Cardiovasc Genet"},{"key":"5765_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/pr.2016.266","volume":"81","author":"E Suganuma","year":"2017","unstructured":"Suganuma E, Niimura F, Matsuda S, Ukawa T, Nakamura H, Sekine K, Kato M, Aiba Y, Koga Y, Hayashi K et al (2017) Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease. Pediatr Res 81:593\u2013600. https:\/\/doi.org\/10.1038\/pr.2016.266","journal-title":"Pediatr Res"},{"key":"5765_CR14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.echo.2016.03.017","volume":"29","author":"T Kobayashi","year":"2016","unstructured":"Kobayashi T, Fuse S, Sakamoto N, Mikami M, Ogawa S, Hamaoka K, Arakaki Y, Nakamura T, Nagasawa H, Kato T et al (2016) A new Z score curve of the coronary arterial internal diameter using the lambda-mu-sigma method in a pediatric population. J Am Soc Echocardiogr 29:794\u2013801. https:\/\/doi.org\/10.1016\/j.echo.2016.03.017","journal-title":"J Am Soc Echocardiogr"},{"key":"5765_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/archdischild-2020-319810","volume":"106","author":"KG Friedman","year":"2021","unstructured":"Friedman KG, Gauvreau K, Baker A, Son MB, Sundel R, Dionne A, Giorgio T, De Ferranti S (2021) Newburger JW (2021) Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. Arch Dis Child 106:247\u2013252. https:\/\/doi.org\/10.1136\/archdischild-2020-319810","journal-title":"Arch Dis Child"},{"key":"5765_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/01.CIR.75.2.387","volume":"75","author":"M Takahashi","year":"1987","unstructured":"Takahashi M, Mason W, Lewis A (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75:387\u2013394. https:\/\/doi.org\/10.1161\/01.CIR.75.2.387","journal-title":"Circulation"},{"key":"5765_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0022-3476(05)81894-3","volume":"121","author":"T Akagi","year":"1992","unstructured":"Akagi T, Rose V (1992) Bensen LN Freedom RM (1992) Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 121:689\u2013694. https:\/\/doi.org\/10.1016\/S0022-3476(05)81894-3","journal-title":"J Pediatr"},{"key":"5765_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ijcard.2018.04.062","volume":"271","author":"Y Nagatomo","year":"2018","unstructured":"Nagatomo Y, Muneuchi J, Nakashima Y, Nanishi E, Shirozu H, Watanabe M, Uike K, Nagata H, Hirata Y, Yamamura K et al (2018) Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease. Int J Cardiol 271:317\u2013321. https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.062","journal-title":"Int J Cardiol"},{"key":"5765_CR19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3675","volume":"143","author":"MA Portman","year":"2019","unstructured":"Portman MA, Dahdah NS, Slee A, Olson AK, Choueiter NF, Soriano BD, Buddhe S, Altman CA (2019) Etanercept with IVIg for acute Kawasaki disease: a randomized controlled trial. Pediatrics 143:e20183675. https:\/\/doi.org\/10.1542\/peds.2018-3675","journal-title":"Pediatrics"},{"key":"5765_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1017\/S1047951122001470","volume":"33","author":"E Sagiv","year":"2023","unstructured":"Sagiv E, Slee A, Buffone A, Choueiter NF, Dahdah NS, Portman MA (2023) Etanercept with IVIg for acute Kawasaki disease: a long-term follow-up on the EATAK trial. Cardiol Young 33:613\u2013618. https:\/\/doi.org\/10.1017\/S1047951122001470","journal-title":"Cardiol Young"},{"key":"5765_CR21","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1253\/circj.CJ-11-0928","volume":"76","author":"K Takahashi","year":"2012","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y, Yamada H, Shibuya K, Naoe S (2012) A half-century of autopsy results\u2013incidence of pediatric vasculitis syndromes, especially Kawasaki disease. Circ J 76:964\u2013970. https:\/\/doi.org\/10.1253\/circj.CJ-11-0928","journal-title":"Circ J"},{"key":"5765_CR22","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(07)60242-6","volume":"369","author":"RE Schmieder","year":"2007","unstructured":"Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM (2007) Renin-angiotensin system and cardiovascular risk. Lancet 369:1208\u20131219. https:\/\/doi.org\/10.1016\/S0140-6736(07)60242-6","journal-title":"Lancet"},{"key":"5765_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1203\/01.PDR.0000139426.16381.C8","volume":"56","author":"R Fukazawa","year":"2004","unstructured":"Fukazawa R, Sonobe T, Hamamoto K, Hamaoka K, Sakata K, Asano T, Imai T, Kamisago M, Ohkubo T, Uchikoba Y et al (2004) Possible synergic effect of angiotensin-I converting enzyme gene insertion\/deletion polymorphism and angiotensin-II type-1 receptor 1166A\/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res 56:597\u2013601. https:\/\/doi.org\/10.1203\/01.PDR.0000139426.16381.C8","journal-title":"Pediatr Res"},{"key":"5765_CR24","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10238-022-00933-x","volume":"23","author":"Y Gan","year":"2023","unstructured":"Gan Y, Feng Y, Zhou X, Li H, Wang G, Aini M, Shu J, Tu D (2023) Serum levels of angiotensin-converting enzyme 2 in children with Kawasaki disease. Clin Exp Med 23:1325\u20131330. https:\/\/doi.org\/10.1007\/s10238-022-00933-x","journal-title":"Clin Exp Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-024-05765-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T18:03:32Z","timestamp":1728929012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-024-05765-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["5765"],"URL":"https:\/\/doi.org\/10.1007\/s00431-024-05765-3","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"9 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki and the ethical guidelines of the Ministry of Health, Labour and Welfare and was approved by the Central Ethics Committee of Tokyo Metropolitan Children\u2019s Medical Center (approval number: H28b-60). The study was registered in the University Hospital Medical Information Network Clinical Trials Registry under UMIN000024768.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}